Herbal laxatives and antiemetics in pregnancy

Reproductive Toxicology

Volumn 72, Issue , 2017, Pages 153-158

  Samavati, Reza ^a   Ducza, Eszter ^a   Hajagos Tóth, Judit ^a   Gaspar, Robert ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antiemetic; Herbal; Laxatives; Pregnancy; Safety

Indexed keywords

ANTIEMETIC AGENT; EMODIN; FENUGREEK EXTRACT; FOENICULUM VULGARE EXTRACT; HERBACEOUS AGENT; LAXATIVE; LINSEED OIL; PLANT MEDICINAL PRODUCT;

ARTICLE; CHEMICAL TERATOGENESIS; CONSTIPATION; DRUG SAFETY; FENNEL; FENUGREEK; FETUS DISEASE; GESTATION PERIOD; GINGER; HERBAL MEDICINE; HUMAN; LINSEED; NAUSEA; NEUROLOGIC DISEASE; NONHUMAN; PLANT SEED; PREGNANCY; RHUBARB; SENNA OCCIDENTALIS; SYSTEMATIC REVIEW; VOMITING; ANIMAL; FEMALE;

ANIMALS; ANTIEMETICS; FEMALE; HUMANS; LAXATIVES; PLANT PREPARATIONS; PREGNANCY;

EID: 85020689578     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2017.06.041     Document Type: Article

References (48)

1. Zomerdijk, I.M., Ruiter, R., Houweling, L.M.A., Herings, R.M.C., Straus, S.M.J.M., Stricker, B.H., Dispensing of potentially teratogenic drugs before conception and during pregnancy: a population-based study. BJOG: Int. J. Obstet. Gynaecol. 122 (2015), 1119–1129, 10.1111/1471-0528.13128.
2. Pallivalapila, A.R., Stewart, D., Shetty, A., Pande, B., Singh, R., McLay, J.S., Use of complementary and alternative medicines during the third trimester. Obstet. Gynecol. 125 (2015), 204–211, 10.1097/AOG.0000000000000596.
3. Teng, L., Shaw, D., Barnes, J., Characteristics and practices of traditional Chinese medicine retail shops in London, UK: a cross-sectional study using an observational approach. J. Ethnopharmacol. 173 (2015), 318–329, 10.1016/j.jep.2015.07.027.
4. Shin, G.H., Toto, E.L., Schey, R., Pregnancy and postpartum bowel changes: constipation and fecal incontinence. Am. J. Gastroenterol. 110 (2015), 521–529, 10.1038/ajg.2015.76.
5. Poskus, T., Buzinskiene, D., Drasutiene, G., Samalavicius, N.E., Barkus, A., Barisauskiene, A., Tutkuviene, J., Sakalauskaite, I., Drasutis, J., Jasulaitis, A., Jakaitiene, A., Haemorrhoids and anal fissures during pregnancy and after childbirth: a prospective cohort study. BJOG: Int. J. Obstet. Gynaecol. 121 (2014), 1666–1671, 10.1111/1471-0528.12838.
6. Rungsiprakarn, P., Laopaiboon, M., Sangkomkamhang, U.S., Lumbiganon, P., Pratt, J.J., Interventions for treating constipation in pregnancy. Cochrane Database Syst. Rev., 9, 2015, CD011448, 10.1002/14651858 CD011448.pub2.
7. Einarson, T.R., Piwko, C., Koren, G., Prevalence of nausea and vomiting of pregnancy in the USA: a meta-analysis. J. Popul. Ther. Clin. Pharmacol., 20, 2013.
8. Castillo, M.J., Phillippi, J.C., Hyperemesis gravidarum a holistic overview and approach to clinical assessment and management. J. Perinat. Neonatal Nurs. 29 (2015), 12–22, 10.1097/JPN.0000000000000075.
9. Magee, L.A., Chandra, K., Mazzotta, P., Stewart, D., Koren, G., Guyatt, G.H., Development of a health-related quality of life instrument for nausea and vomiting of pregnancy. Am. J. Obstet. Gynecol. 186 (2002), S232–S238, 10.1067/mob.2002.122604.
10. Chang, M.H., Huang, F.J., Chan, W.H., Emodin induces embryonic toxicity in mouse blastocysts through apoptosis. Toxicology 299 (2012), 25–32, 10.1016/j.tox.2012.05.006.
11. Jahnke, G.D., Price, C.J., Marr, M.C., Myers, C.B., George, J.D., Developmental toxicity evaluation of emodin in rats and mice. Birth Defects Res. B: Dev. Reprod. Toxicol. 101 (2004), 89–101, 10.1002/bdrb.20002.
12. Luo, T., Li, N., qiao He, Y., qi Weng, S., Wang, T., xing Zou, Q., hui Zeng, X., Emodin inhibits human sperm functions by reducing sperm [Ca2+]i and tyrosine phosphorylation. Reprod. Toxicol. 51 (2015), 14–21, 10.1016/j.reprotox.2014.11.007.
13. Ouzir, M., El Bairi, K., Amzazi, S., Toxicological properties of fenugreek (Trigonella foenum graecum). Food Chem. Toxicol. 96 (2016), 145–154, 10.1016/j.fct.2016.08.003.
14. Sethi, N., Nath, D., Singh, R.K., Srivastava, R.K., Antifertility and teratogenic activity of some indigenous medicinal plants in rats. Fitoterapia, 61, 1990.
15. Araee, M., Norouzi, M., Habibi, G., Sheikhvatan, M., Toxicity of Trigonella foenum graecum (Fenugreek) in bone marrow cell proliferation in rat. Pak. J. Pharm. Sci. 22 (2009), 126–130.
16. Mozaffari, Z., Azarnia, M., a Angaji, S., Evaluation of toxic effects of Trigonella foenum-graecum leaf aqueous extract on development of long bone tissue in rat fetus. J. Med. Plants Res. 4 (2010), 1148–1155, 10.5897/JMPR09.437.
17. Khalki, L., Bennis, M., Sokar, Z., Ba-m, S., The developmental neurobehavioral effects of fenugreek seeds on prenatally exposed mice. J. Ethnopharmacol. 139 (2012), 672–677, 10.1016/j.jep.2011.12.011.
18. Kassem, A., Al-Aghbari, A., Al-Habori, M., Al-Mamary, M., Evaluation of the potential antifertility effect of fenugreek seeds in male and female rabbits. Contraception 73 (2006), 301–306, 10.1016/j.contraception.2005.08.020.
19. Korman, S.H., Cohen, E., Preminger, A., Pseudo-maple syrup urine disease due to maternal prenatal ingestion of fenugreek. J. Paediatr. Child Health 37 (2001), 403–404, 10.1046/j.1440-1754.2001.00617.x.
20. Goyal, A., Sharma, V., Upadhyay, N., Gill, S., Sihag, M., Flax and flaxseed oil: an ancient medicine & modern functional food. J. Food Sci. Technol. 51 (2014), 1633–1653, 10.1007/s13197-013-1247-9.
21. Thompson, L.U., Robb, P., Serraino, M., Cheung, F., Mammalian lignan production from various foods. Nutr. Cancer 16 (1991), 43–52, 10.1080/01635589109514139.
22. Ward, W.E., Chen, J., Thompson, L.U., Exposure to flaxseed or its purified lignan during suckling only or continuously does not alter reproductive indices in male and female offspring. J. Toxicol. Environ. Health A 64 (2001), 567–577, 10.1080/15287390152627246.
23. Ward, W.E., Yuan, Y.V., Cheung, a M., Thompson, L.U., Exposure to purified lignan from flaxseed (Linum usitatissimum) alters bone development in female rats. Br. J. Nutr. 86 (2001), 499–505, 10.1079/BJN2001429.
24. Tou, J.C.L., Thompson, L.U., Exposure to flaxseed or its lignan component during different developmental stages influences rat mammary gland structures. Carcinogenesis 20 (1999), 1831–1835, 10.1093/carcin/20.9.1831.
25. Khan, G., Penttinen, P., Cabanes, A., Foxworth, A., Chezek, A., Mastropole, K., Yu, B., Smeds, A., Halttunen, T., Good, C., Sari, M., Maternal flaxseed diet during pregnancy or lactation increases female rat offspring's susceptibility to carcinogen-induced mammary tumorigenesis. Reprod. Toxicol. 23 (2007), 397–406, 10.1016/j.reprotox.2007.02.002.
26. Collins, T.F., Sprando, R.L., Black, T.N., Olejnik, N., Wiesenfeld, P.W., Babu, U.S., Bryant, M., Flynn, T.J., Ruggles, D.I., Effects of flaxseed and defatted flaxseed meal on reproduction and development in rats. Food Chem. Toxicol. 41 (2003), 819–834, 10.1016/S0278-6915(03)00033-4.
27. Aragão, T.P., Lyra, M.M.A., Silva, M.G.B., Andrade, B.A., Ferreira, P.A., Ortega, L.F., da Silva, S.D., da Silva, J.C.P., Fraga, M.C.C.A., Wanderley, A.G., Lafayette, S.S.L., Toxicological reproductive study of Cassia occidentalis L. in female Wistar rats. J. Ethnopharmacol. 123 (2009), 163–166, 10.1016/j.jep.2008.11.030.
28. Barbosa-Ferreira, M., Pfister, J.A., Gotardo, A.T., Maiorka, P.C., Górniak, S.L., Intoxication by Senna occidentalis seeds in pregnant goats: prenatal and postnatal evaluation. Exp. Toxicol. Pathol. 63 (2011), 263–268, 10.1016/j.etp.2010.01.004.
29. Ács, N., Bánhidy, F., Puhó, E.H., Czeizel, A.E., Senna treatment in pregnant women and congenital abnormalities in their offspring-a population-based case-control study. Reprod. Toxicol. 28 (2009), 100–104, 10.1016/j.reprotox.2009.02.005.
30. Ács, N., Bánhidy, F., Puhó, E.H., Czeizel, A.E., No association between severe constipation with related drug treatment in pregnant women and congenital abnormalities in their offspring: a population-based case-control study. Congenit. Anom. (Kyoto) 50 (2010), 15–20, 10.1111/j.1741-4520.2009.00252.x.
31. Benevenuto, S.G., Domenico, M.D., Martins, M.A.G., Costa, N.S., de Souza, A.R.L., Costa, J.L., Tavares, M.F.M., Dolhnikoff, M., Veras, M.M., Recreational use of marijuana during pregnancy and negative gestational and fetal outcomes: an experimental study in mice. Toxicology 376 (2015), 94–101, 10.1016/j.tox.2016.05.020.
32. Shabani, M., Hosseinmardi, N., Haghani, M., Shaibani, V., Janahmadi, M., Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring. Neuroscience 172 (2011), 139–152, 10.1016/j.neuroscience.2010.10.031.
33. Schneider, M., Cannabis use in pregnancy and early life and its consequences: animal models. Eur. Arch. Psychiatry Clin. Neurosci. 259 (2009), 383–393, 10.1007/s00406-009-0026-0.
34. Leemaqz, S.Y., Dekker, G.A., McCowan, L.M., Kenny, L.C., Myers, J.E., Simpson, N.A.B., Poston, L., Roberts, C.T., Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications. Reprod. Toxicol. 62 (2016), 77–86, 10.1016/j.reprotox.2016.04.021.
35. Conner, S.N., Carter, E.B., Tuuli, M.G., MacOnes, G.A., Cahill, A.G., Maternal marijuana use and neonatal morbidity presented as a poster at the 35th annual meeting of the society for maternal-fetal medicine, San Diego, CA, Feb. 2–7, 2015. Am. J. Obstet. Gynecol. 213 (2015), 422e1–422e4, 10.1016/j.ajog.2015.05.050.
36. Calvigioni, D., Hurd, Y.L., Harkany, T., Keimpema, E., Neuronal substrates and functional consequences of prenatal cannabis exposure. Eur. Child Adolesc. Psychiatry 23 (2014), 931–941, 10.1007/s00787-014-0550-y.
37. Jutras-Aswad, D., DiNieri, J.A., Harkany, T., Hurd, Y.L., Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur. Arch. Psychiatry Clin. Neurosci. 259 (2009), 395–412, 10.1007/s00406-009-0027-z.
38. Hayatbakhsh, M.R., Flenady, V.J., Gibbons, K.S., Kingsbury, A.M., Hurrion, E., Mamun, A.A., Najman, J.M., Birth outcomes associated with Cannabis use before and during pregnancy. Pediatr. Res. 71 (2012), 215–219, 10.1038/pr.2011.25.
39. Metz, T.D., Stickrath, E.H., Marijuana use in pregnancy and lactation: a review of the evidence. Am. J. Obstet. Gynecol. 213 (2015), 761–778, 10.1016/j.ajog.2015.05.025.
40. Ostad, S.N., Soodi, M., Shariffzadeh, M., Khorshidi, N., Marzban, H., The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea, pharmacology and toxicology study. J. Ethnopharmacol. 76 (2001), 299–304, 10.1016/S0378-8741(01)00249-5.
41. Ostad, S.N., Khakinegad, B., Sabzevari, O., Evaluation of the teratogenicity of fennel essential oil (FEO) on the rat embryo limb buds culture. Toxicol. Vitro 18 (2004), 623–627, 10.1016/j.tiv.2004.02.008.
42. Trabace, L., Tucci, P., Ciuffreda, L., Matteo, M., Fortunato, F., Campolongo, P., Trezza, V., Cuomo, V., Natural relief of pregnancy-related symptoms and neonatal outcomes: above all do no harm. J. Ethnopharmacol. 174 (2015), 396–402, 10.1016/j.jep.2015.08.046.
43. Mohammed, O.J., Latif, M.L., Pratten, M.K., Evaluation of embryotoxicity for major components of herbal extracts using the chick embryonic heart micromass and mouse D3 embryonic stem cell systems. Reprod. Toxicol. 59 (2016), 117–127, 10.1016/j.reprotox.2015.12.003.
44. Wilkinson, J.M., Effect of ginger tea on the fetal development of Sprague-Dawley rats. Reprod. Toxicol. 14 (2000), 507–512, 10.1016/S0890-6238(00)00106-4.
45. Boone, S.A., Shields, K.M., Treating pregnancy-related nausea and vomiting with ginger. Ann. Pharmacother. 39 (2005), 1710–1713, 10.1345/aph.1G086.
46. Marcus, D.M., Snodgrass, W.R., Do no harm: avoidance of herbal medicines during pregnancy. Obstet. Gynecol. 105 (2005), 1119–1122, 10.1097/01.AOG.0000173415.38704.0e.
47. Ding, M., Leach, M., Bradley, H., The effectiveness and safety of ginger for pregnancy-induced nausea and vomiting: a systematic review. Women Birth, 26, 2013, 10.1016/j.wombi.2012.08.001.
48. Knudsen, V.K., Hansen, H.S., Osterdal, M.L., Mikkelsen, T.B., Mu, H., Olsen, S.F., Fish oil in various doses or flax oil in pregnancy and timing of spontaneous delivery: a randomised controlled trial. BJOG 113:5 (2006), 536–543.